First extensive immune profiling of sarcomas shows some likely susceptible to immunotherapy June 01, 2017Vol.40 No.05
Part 2 of phase III study of binimetinib and encorafenib produces positive top-line result June 01, 2017Vol.40 No.05
Mutations in pancreatic cancer provide clues on development of pancreatic cancer June 01, 2017Vol.40 No.05
AUA publishes list of tests and treatments to question as part of “Choosing Wisely” June 01, 2017Vol.40 No.05
Imfinzi reduces the risk of disease worsening or death in the phase III PACIFIC trial in stage III disease June 01, 2017Vol.40 No.05
